SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001387131-20-004964
Filing Date
2020-05-19
Accepted
2020-05-19 08:49:25
Documents
1
Group Members
AIGH CAPITAL MANAGEMENT, LLCAIGH INVESTMENT PARTNERS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G acer-sc13g_051420.htm SC 13G 111849
  Complete submission text file 0001387131-20-004964.txt   113512
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81104 | Film No.: 20891664
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Filed by) CIK: 0001131362 (see all company filings)

Type: SC 13G